Codex DNA Inc. (DNAY)
NASDAQ: DNAY
· Real-Time Price · USD
1.30
0.10 (8.33%)
At close: Jan 04, 2023, 6:00 AM
Codex DNA Revenue Breakdown
| Period Ending | Dec 31, 2022 |
|---|---|
| Collaboration Revenue Revenue | 6.65M |
| Collaboration Revenue Revenue Growth | n/a |
| Product Revenue | 10.91M |
| Product Revenue Growth | n/a |
| Royalties And Other Revenue Revenue | 2.75M |
| Royalties And Other Revenue Revenue Growth | n/a |
| Service Revenue | 7.12M |
| Service Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 3.98M | 7.21M | 9M | 9.07M | 9.36M | 10.19M | 9.09M | 10.07M | 9.26M | 7.65M | 7.01M | 5.78M | 4.69M | 3.43M | 2.85M | 2.34M | 2.44M |
| Selling, General, and Administrative Revenue Growth | -44.77% | -19.94% | -0.80% | -3.09% | -8.14% | +12.06% | -9.74% | +8.80% | +21.08% | +9.10% | +21.30% | +23.27% | +36.80% | +20.20% | +21.94% | -4.38% | n/a |
| Research and Development Revenue | 2.17M | 2.47M | 4.12M | 4.59M | 5.12M | 4.14M | 5.82M | 7.12M | 6.38M | 5.33M | 3.59M | 2.75M | 2.88M | 2.66M | 2.35M | 1.96M | 1.96M |
| Research and Development Revenue Growth | -11.98% | -40.03% | -10.20% | -10.43% | +23.73% | -28.83% | -18.36% | +11.64% | +19.70% | +48.37% | +30.84% | -4.59% | +8.11% | +13.52% | +19.95% | -0.41% | n/a |
| Sales and Marketing Revenue | 880K | 1.7M | 2.74M | 3.36M | 3.81M | 4.68M | 3.83M | 4.51M | 3.46M | 3.04M | 2.96M | 2.63M | 2.27M | 2.17M | 1.86M | 1.6M | 1.3M |
| Sales and Marketing Revenue Growth | -48.17% | -38.10% | -18.36% | -11.74% | -18.67% | +22.12% | -15.09% | +30.42% | +14.00% | +2.74% | +12.36% | +15.60% | +4.69% | +16.77% | +16.46% | +23.02% | n/a |